Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Reference
Sodhi, C. P. et al. The human milk oligosaccharides 2’-fucosyllactose and 6’-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling. Pediatr. Res. https://doi.org/10.1038/s41390-020-0852-3 (2020).
Acknowledgements
D.J.H. is supported by R01GM078238 and R01DK083752 from the National Institutes of Health, and this research was funded in part by a Sponsored Research Grant to D.J.H. from Abbott Nutrition.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Statement of consent
Samples were obtained de-identified under IRB 00094036 and consent was not required.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sodhi, C.P., Wipf, P., Yamaguchi, Y. et al. Insights image for “The human milk oligosaccharides 2’-fucosyllactose and 6’-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling.”. Pediatr Res 89, 248 (2021). https://doi.org/10.1038/s41390-020-01184-w
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41390-020-01184-w
